1. Overview
  2. All Stocks
  3. Rentokil Initial plc

Rentokil Initial (RKLIF.US) Dividend 2026/2027: 2.1% – Rating and Stock Analysis

5,93
Analysis framework by , founder of TradeDesk · Data: EODHD, official filings (SEC) · Updated
Share this analysis:

No analysts currently cover Rentokil Initial with a public price target. We add the price target automatically as soon as at least one analyst publishes a rating. Until then, use the technical analysis and the key figures below.

About Rentokil Initial – Specialty Business Services

Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, Europe, the United Kingdom, Asia, the Middle East, North Africa, Turkey, and Pacific. The company offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management. It provides hygiene services, including the provision and maintenance of products, such as soap and hand sanitizer dispensers, hand dryers, air care and purification, cubicle and surface sanitizers, feminine hygiene units, toilet paper dispensers, and floor protection mats. In addition, the company engages in the supply and laundering of garments for commercial organizations. Further, the company provides a range of specialist cleaning services, such as graffiti removal, deep cleaning of kitchens and washrooms, trauma cleaning, and flood or fire damage cleaning, as well as specialist deep cleaning services. Rentokil Initial plc was founded in 1903 and is headquartered in Crawley, the United Kingdom. Read more about the company

Key Figures for Rentokil Initial

$ 12,3B Market cap
$ 7,1B Revenue
Specialty Business Services Industry
44.27 P/E
1.72 P/S
2.71 P/B
USA Listed on exchange
rentokil-initial.com Website
Industri Sector

What kind of stock is Rentokil Initial?

Quality stock

Rentokil Initial is classified as a quality stock with a Piotroski score of 8/9 and a quality score in the top 28% of all stocks.

Score Overview for Rentokil Initial

💰 Value Score 45/100 (Neutral)
⭐ Quality Score 72/100 (High)
🚀 Momentum Score 62/100 (High)
📊 Total Score 59/100

⚠️ 1 red flag identified

Our analysis has identified 1 potential risk factor in Rentokil Initial that investors should be aware of.

⚠️ Unsustainable dividend: The payout ratio is 103% – the company pays out more in dividends than it earns, which is not sustainable.

📈 Valuation

Rentokil Initial trades at a P/E ratio of 44.3, which is above the market average. The forward P/E is 18.0 (59% lower), which suggests the market expects rising earnings. The P/S ratio is 1.7. The P/B ratio is 2.7. The PEG ratio is 1.13.

💵 Profitability & Growth

Rentokil Initial has a profit margin of 6.7% (moderate) and an operating margin of 12.8%. Return on equity (ROE) is 6.0%. Return on assets (ROA) is 4.0%. The latest quarterly earnings grew 4.2% year over year.

🏦 Financial Health

The Piotroski score is 8 out of 9 — excellent financial health. Altman Z2 is 3.62 (healthy balance sheet — low risk). The debt-to-equity ratio (D/E) is 149.6% — moderate debt.

↑ Back to navigation

Rentokil Initial Dividend 2026: 2.1% Dividend Yield

Dividend Key Figures for Rentokil Initial in 2026

Dividend yield
2.10%
Dividend per share
0.08 USD
Payout ratio
103.4%
Very high
Dividend growth (4 years)
+300.0%
Avg. annual dividend (3 years)
0.11 USD

When does Rentokil Initial pay a dividend in 2026?

Latest ex-dividend date (traded without the dividend)
April 10, 2026
Latest payment date
May 18, 2026

How much does Rentokil Initial pay in dividends?

Rentokil Initial pays dividends to its shareholders. The most recently paid dividend was 0.08 USD per share, which corresponds to a dividend yield of 2.10%. Over the last 4 years, the annual dividend has grown by 300.0%, which shows positive dividend growth.

The payout ratio is 103.4%, which is very high. The company pays out almost all of its profits as dividends, which can limit future growth and dividend stability.

Historical Dividend Payments for Rentokil Initial

We have registered dividend payments for Rentokil Initial since 2021-08-05. In that period the stock has paid a dividend 10 times, most recently on 2026-04-10. This stock qualifies as a stable dividend stock, because it has paid a dividend at least once a year for the last 5 years. That makes it attractive to investors looking for steady, regular dividend payments.

Ex-datePayment dateAmountCurrencyPeriod
2026-04-102026-05-180.08USDUnknown period
2025-08-152025-09-220.04USDUnknown period
2025-04-042025-05-140.08USDUnknown period
2024-08-092024-09-160.04USDUnknown period
2024-04-042024-05-150.08USDUnknown period
2023-08-032023-09-110.04USDUnknown period
2023-04-102023-05-170.06USDUnknown period
2022-08-042022-09-120.03USDUnknown period
2022-04-072022-05-180.06USDUnknown period
2021-08-052021-09-130.03USDUnknown period
↑ Back to navigation

When Does Rentokil Initial Report Earnings?

The next earnings date for Rentokil Initial is not yet available. Check the company's investor calendar for more information.



↑ Back to navigation

Technical Analysis of Rentokil Initial 2026 – Signal: Sell

Overall Technical Signal: Sell

Based on trend analysis (SMA50/SMA200) and MACD trend (positive/negative on a daily + weekly basis). Updated August 6, 2026.

Trend Analysis of Rentokil Initial plc

Rentokil Initial plc is in a short-term uptrend. The price of $5.93 is 0.0% above the 20-day average ($5.93). Medium term, the picture is negative: the price is 0.6% below the 50-day average ($5.97). Long term, the stock is 1.7% above the 200-day average ($5.83), which confirms a long-term uptrend.

Golden Cross: The 50-day average (5.97) is above the 200-day average (5.83), which is a classic bullish signal for Rentokil Initial plc.

Is Rentokil Initial plc overbought or oversold?

Rentokil Initial plc has an RSI of 22.7, which places the stock in oversold territory (below 30). The trend is neutral, so the oversold level should be interpreted with caution. Wait for confirmation from MACD or a trend reversal.

MACD Analysis for Rentokil Initial plc

Daily MACD: MACD is negative (-0.011), which means the short-term trend is bearish (the 12-day EMA is below the 26-day EMA). MACD is above the signal line (-0.016) by 0.005, which suggests the negative momentum is fading – a potential trend reversal could be ahead.

Weekly MACD: MACD5 is negative (-0.013), which indicates a broader bearish long-term trend. MACD5 is above the signal line (-0.064) by 0.051, which suggests the negative long-term momentum is fading – a bigger trend reversal could be ahead.

Overall MACD assessment: Both the daily and weekly trend are bearish (MACD negative). However, momentum shows signs of improving on a daily basis – a potential trend reversal could be ahead, but it is not confirmed yet.

Risk Profile for Rentokil Initial plc

Rentokil Initial plc has an annual standard deviation of 30.5%, which classifies the stock as moderately low risk. There is some volatility, but the price is relatively stable.

Overall Technical Conclusion for Rentokil Initial plc

Trend: Neutral/mixed.

MACD trend (zero line): Daily bearish (-0.011). Weekly bearish (-0.013).

MACD momentum (signal): Daily rising. Weekly rising.

RSI: 22.7 – oversold.

Technical signal: Sell

The trend is negative and MACD is below the zero line, which confirms the bearish momentum. Consider reducing the position or setting a stop-loss.

↑ Back to navigation

Frequently Asked Questions About Rentokil Initial stock in 2026

Should you buy Rentokil Initial stock now?
No, the technical signal for Rentokil Initial is currently SELL. Rentokil Initial trades at $5.93 as of 8/6/2026. The overall technical signal is: Sell. The technical analysis shows the following: MACD is negative (bearish trend) at -0.011 with rising momentum (signal: -0.016); RSI is at 22.7 (oversold), which could point to a potential buying opportunity; the stock is in a short-term downtrend (price below the 20-day average). This is a technical observation based on current data, not investment advice.
What is the price target for Rentokil Initial stock?
There is currently no active analyst price target for Rentokil Initial.
Is Rentokil Initial a dividend stock?
Yes, Rentokil Initial is a dividend stock with a dividend yield of 2.10%. The latest dividend was $0.08 per share. The latest ex-dividend date (traded without the dividend) was 4/10/2026. The payout ratio is 103.4%, which is considered high.
When does Rentokil Initial pay a dividend in 2026?
The next dividend date for Rentokil Initial has not been set yet. The latest ex-dividend date (last trading day with dividend rights) was 4/10/2026. The latest dividend was $0.08 per share with an ex-dividend date of 4/10/2026. The dividend yield is 2.10%. The payout ratio of 103.4% points to a high dividend relative to earnings.
What is the risk of Rentokil Initial stock?
Rentokil Initial is rated as a stock with moderately low risk. the annual standard deviation is 30.5%, which classifies the stock as moderately low risk. In addition, an RSI of 22.7 signals oversold (potential bottom).
Is Rentokil Initial overvalued?
Rentokil Initial has the following valuation ratios: a P/E ratio of 44.3 (highly valued), a P/S ratio of 1.7, a P/B ratio of 2.7.
Is Rentokil Initial overbought?
No, Rentokil Initial is actually oversold with an RSI of 22.7 (below 30). The technical indicators show: RSI is at 22.7 (below the 30 mark), which actually signals the price is oversold – the opposite of overbought. In addition, the price is 0.0% below the 20-day average (short-term downtrend). In addition, MACD is negative, but momentum is rising (possible trend reversal).
When is the next Rentokil Initial earnings report?
The date of the next earnings report for Rentokil Initial has not been published yet. Check the company's investor calendar for updates.
Is Rentokil Initial shorted?
There is currently no registered short interest for Rentokil Initial, or the data is not available.
Are insiders buying Rentokil Initial stock?
There is currently no registered insider trading for Rentokil Initial.
Is Rentokil Initial a good stock?
Based on our total score, Rentokil Initial is rated as a good stock with a total score of 60 out of 100. The stock scores above average on value, quality and momentum – it is among the top 40% in our database. The score is made up of Value: 45/100, Quality: 72/100, Momentum: 62/100. In addition: a dividend of 2.10%; technical signal: Sell. Whether Rentokil Initial is a good investment depends on your time horizon, risk profile and portfolio. This is a data-driven observation, not investment advice.
What is the outlook for Rentokil Initial stock?
The outlook for Rentokil Initial based on current data: the P/E ratio is 44.3 (high – the market expects growth). Keep in mind that stock prices are affected by many factors, including earnings reports, the economy and market sentiment. Past returns are no guarantee of future returns.
Why is Rentokil Initial stock moving?
Rentokil Initial is stable right now. The technical indicators show: the price is close to the 20-day average. For the latest context, see our technical analysis, insider section and news overview above.
How high can Rentokil Initial go?
There is currently no active analyst price target for Rentokil Initial. Keep in mind that price targets are estimates, not guarantees. Actual price moves depend on earnings, market conditions and unexpected events.
How low can Rentokil Initial fall?
We lack enough history to give a specific floor for Rentokil Initial. Remember: past price swings are no guarantee for the future — a stock can fall further than the last 52 weeks suggest, especially on profit warnings, sector crises or a market crash. Use stop-loss orders and spread your portfolio to limit losses in single stocks.
What does Rentokil Initial do?
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, Europe, the United Kingdom, Asia, the Middle East, North Africa, Turkey, and Pacific. The company offers a range of pest control services for rodents, and flying and crawling ... The company belongs to the Industri sector, more specifically the Specialty Business Services industry, is headquartered in USA, and is traded on the USA Stocks. See the key figures, earnings history and price development above to evaluate Rentokil Initial as an investment.
Did Rentokil Initial raise or lower its guidance?
Over the last 60 days we have not registered a guidance raise or cut from Rentokil Initial. The company can still adjust its guidance at quarterly reports or between reports — see the earnings history and the news overview above.
Is Rentokil Initial making money or losing money?
Yes, Rentokil Initial is making money, not losing it. The company has a profit margin (the share of revenue left over as profit) of 6.7% — which is moderate. The operating margin (profit before interest and taxes) is 12.8%. At a P/E ratio of 44.3, you currently pay 44.3 dollars for every dollar of the company's annual earnings. A consistently profitable company is usually more resilient than growth stocks that are not yet making money.
Can Rentokil Initial go bankrupt?
The bankruptcy risk of Rentokil Initial is rated as low. Altman Z2 (a model for assessing financial distress) is 3.62 — that places the company in the healthy zone. The company has a healthy balance sheet with limited debt relative to earnings and assets. The Piotroski score (financial health 0-9, higher is better) is 8 — which is strong. Debt relative to equity is 150% (moderate). Remember: models like Altman Z2 are statistical — unexpected shocks (fraud, a sector collapse, lawsuits) can always happen. Spread your portfolio.
Does Rentokil Initial have a lot of debt?
Rentokil Initial has moderate debt relative to equity. The debt-to-equity ratio (D/E — interest-bearing debt to equity) is 150%. For the industri sector, 80-150% counts as a typical level. Note: D/E levels are highly sector-specific — a bank at 300% debt is normal, a tech stock at 300% is extremely leveraged. Always compare with similar companies in the same sector. Can Rentokil Initial service its debt? Can service its debt, but it weighs on the company — the interest coverage ratio (how many times earnings can cover interest payments) is 4.0x, and net debt equals 2.9 years of earnings (EBITDA).
↑ Back to navigation

Explore More